Aker BioMarine Logo

Aker BioMarine

ISIN: NO0010886625 | Ticker: AKBM | LEI: 549300MU8WPXD29E3I11
Sector: Health CareSub-Industry: Biotechnology
Country: Norway

About Aker BioMarine

Company Description

Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities.

The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.

Year founded

2006

Served area

Worldwide

Headquarters

Oksenøyveien 10, 1327 Lysaker – Norway

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

NO0010886625

LEI

549300MU8WPXD29E3I11

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Oslo Børs

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.